Heart Disease, Technology / 19.04.2022
AFib: BioSig Technologies PURE EP™ System Improves Intracardiac Signaling During Ablation Procedures
Ken Londoner, MBA
Founder, Chief Executive Officer, Chairman, and Director
BioSig Technologies
MedicalResearch.com: Would you briefly describe the condition of Atrial fibrillation (AFib)?
Whom does AFib primarily affect and how common is it? What are the potential complication of AFib?
Response: Atrial Fibrillation, or Afib—the most common heart rhythm disturbance—affects over 33 million people across the globe. Afib is caused by faulty electrical signals in the upper chambers of the heart (the atria) that cause it to beat too fast or irregularly—often more than 400 beats per minute.* The condition can lead to serious health consequences, including stroke, blood clots, or sudden cardiac arrest. Stroke is among the most serious health concerns for Afib patients, with research suggesting a Afib carries a 5-fold increased risk of stroke— especially when Afib is left untreated.
With a lifetime risk of more than 20 percent*, Afib can affect anyone. However, the condition is most common in those 65 years and older. Individuals with underlying health complications, including heart disease, high blood pressure, thyroid problems, or excessive alcohol use are also at a greater risk of developing Afib.*
(more…)